2 news items
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update
ELVN
14 May 24
to attract, hire, and retain highly skilled executive officers and employees; the ability of Enliven to protect its intellectual property
Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
ELVN
11 Apr 24
executive officers and employees; the ability of Enliven to protect its intellectual property and proprietary technologies; the scope of any patent
- Prev
- 1
- Next